Report
EUR 13.86 For Business Accounts Only

A double requalification allows MEDIDATA SOLUTIONS INCO. to improve to Slightly Positive

MEDIDATA SOLUTIONS INCO. (US), a company active in the Software industry, has received a double requalification by the independent financial analyst theScreener. Its fundamental valuation is now 2 out of 4 stars while its market behaviour can be considered as defensive. theScreener believes that the gain of a star(s) and an improvement in the market risk perception allows upgrading the general evaluation to Slightly Positive. As of the analysis date October 8, 2019, the closing price was USD 91.62 and its potential was estimated at USD 103.74.
Underlying
Medidata Solutions Inc.

Medidata Solutions is a global life sciences technology provider to improve the way clinical research is designed, conducted, analyzed, and commercialized. The company's cloud-based platform of solutions, data analytics, and AI improves quality throughout clinical development programs. The company's Medidata Cloud provides a platform for demonstrating treatment efficacy and safety, supporting regulatory approval, improving outcomes for patients, providers, and payers. It has data capture, management, and reporting family of solutions. The company's services offerings include implementation services, sponsor enablement, strategic consulting, partner support, e-learning and training, and ongoing support.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch